Menu
Back to Journals » OncoTargets and Therapy » Volume 12
Perspectives
Labyrinthin, The Tumor Marker Recognized By MCA 44-3A6: A Case For Pan-Tumor Markers As Targets To Treat Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,033 | Dovepress* | 4,580+ | 579 | 5,159 | |
| PubMed Central* | 453 | 113 | 566 | ||
| Totals | 5,033 | 692 | 5,725 | ||
| *Since 6 November 2019 | |||||
View citations on PubMed and Google Scholar